Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Crestor hailed as first drug to reverse cardiovascular disease

March 14, 2006 Research and Development

Researchers have hailed results from a new study of Crestor which shows it can reverse atherosclerosis, the furring up of …
News

Bright future for NicOx after Pfizer glaucoma deal

March 10, 2006 Research and Development

Shares in the French biotechnology company NicOx have soared after Pfizer snapped up the rights to its pipeline of ophthalmology …
News

Wyeth to open clinical trial ‘Super Centres’

February 23, 2006 Research and Development

Wyeth has unveiled plans to streamline its drug development operations by opening a network of clinical trial 'Super Centres' around …
News

Pfizer’s new blood infection drug Eraxis approved

February 23, 2006 Research and Development

Eraxis, a new treatment for potentially life-threatening fungal infections has been approved in the US.Pfizer's new antifungal is licensed to …
News

Tysabri trials restart after safety scare

February 20, 2006 Research and Development

Clinical trials of Tysabri, the troubled multiple sclerosis treatment, are to begin again in the US after the FDA gave …
News

Avastin trial recruitment suspended after patient deaths

February 16, 2006 Research and Development

Roche has stopped recruiting colon cancer patients who have undergone surgery to a trial of Avastin after four suddenly died.The …
News

Wyeth joins search for promising TLR drugs

February 15, 2006 Research and Development

A new collaboration between Wyeth and an Irish biotech company is to investigate the potential of 'toll like receptors', which …
News

GSK’s research chief leaves for Gates Foundation

February 9, 2006 Research and Development

GlaxoSmithKline's head of research and development Tachi Yamada is to leave the company, having been recruited by Bill Gates to …
News

Humira becomes Britain’s first biotech blockbuster

January 26, 2006 Research and Development

The UK biotech company which discovered rheumatoid arthritis drug Humira has hailed its success after sales passed the $1 billion …
News

Amgen to expand R&D investment in UK

January 26, 2006 Research and Development

Amgen, the world's largest biotechnology company is to open a new drug development centre in Uxbridge, London, as part of …
News

Roche and biotech swap roles in novel collaboration

January 24, 2006 Research and Development

Roche and Amira Pharmaceuticals have entered into a new and unorthodox drug discovery and development partnership which will see them …
News

Next generation monoclonal antibodies to enter clinical trials in 2007

January 20, 2006 Research and Development Ablynx, Novartis

Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …
News

FDA looks to streamline early research

January 19, 2006 Research and Development

The FDA has unveiled plans to allow more small-scale exploratory studies of drugs in humans before formal phase I studies …
News

Right time, right place, right patient

January 17, 2006 Research and Development

With patient recruitment such a key cog in the overall clinical trial machine, pharma and biotech businesses are increasing their …
Feature

Gene discovery offers new diabetes drug target hope

January 16, 2006 Research and Development

A gene thought to be present in around 20% of type II diabetes patients has been identified, opening up the …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026